Kristen Monaco is a Staff Writer at Endocrinology. She covers a range of topics within the realms of medicine and healthcare, including medical specialties, alternative medicine, diagnostics, and wellness, with a particular focus on the FDA, Coronavirus, nutrition, and psychedelics. Kristen's work has been featured in Knowledia and MedPage Today.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Kristen Monaco's articles primarily focus on healthcare and pharmaceuticals, with a strong emphasis on citing data. She covers a wide range of topics including mental health, medical research, diabetes, obesity, and kidney disease. If you have new scientific findings or access to relevant data in these areas, she may be interested in your insights.
As her coverage does not specify any geographic focus and encompasses global issues related to healthcare and pharmaceuticals, consider reaching out with international perspectives or studies that can provide valuable insights into the topics covered in her articles.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Kristen
News and commentary from the endocrinology world
Clinical trials of xenotransplantation expected to kick off next year
By: Kristen
News and commentary from the psychiatry world
Compounders only have 2 to 3 months left to copy injectable
— Antisense oligonucleotide olezarsen slashes high triglycerides
Tirzepatide ok'd for obstructive sleep apnea in people with obesity
— Generic liraglutide approved at dosage for type 2 diabetes only
By: Kristen Monaco
— News and commentary from the endocrinology world The FDA expanded the indication for setmelanotide (Imcivree) opens in a new tab or window
Researchers recommend close kidney function monitoring in hospitalized patients
By: Kristen Monaco
— Persistently getting less than 7 hours tied to higher odds for metabolic syndrome
(833) 317-6278 
